Cellular localization of keratin in proliferative epithelial processes and neoplasms of the human ovary

Other OA: closed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-17 ⓘ

This study analyzed cytokeratin distribution in 23 ovarian epithelial proliferations, finding that distinct localization patterns characterize benign tumors but are lost during progression to borderline and malignant neoplasia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-12 · read from full text ⓘ

This study investigated the cellular distribution of cytokeratin in twenty-three human ovarian specimens ranging from inflammatory reactive processes to malignant neoplasia using immunohistochemistry. The findings revealed that keratin expression was predominantly limited to epithelial cells across benign tumors, borderline tumors, and carcinomas, with specific localization patterns varying by histological type in benign cases. However, these distinct apical or basal localization patterns were lost during cytological progression to borderline and malignant states, where reactivity often concentrated in areas of atypia or basal regions contiguous with the stroma. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Cytokeratins are one of the intermediate cytoplasmic filaments which contribute to the cytoskeleton. Keratins have recently been demonstrated in normal and neoplastic tissues as well as in human cell lines. It has been suggested that the cellular location of keratin may reflect tissue-specific or epithelial type differentiation. Twenty-three examples of human ovaries containing the full spectrum of epithelial proliferations from inflammatory reactive processes to malignant neoplasia were studied for the cellular distribution of cytokeratin using antisera to human keratin. Nineteen cases contained immunoreactive keratin which was limited to the epithelial cells: 2/2 inflammatory, 8/10 benign tumors, 5/7 borderline tumors, 4/4 carcinomas. There was marked regional heterogeneity in keratin expression such that adjacent morphologically-identical cells could be functionally distinguished by the immunoreactive staining. The predominant cellular localization of keratin varied between histological tumor types in the benign neoplasms: serous = apical, subciliary; endometrioid = apical; mucinous = basal. This pattern was lost in the cytological progression to borderline and malignant tumors. In borderline tumors, the most intense reactivity was noted in areas of cellular atypia and proliferation. In borderline and malignant tumors, keratin was usually present in basal cytoplasmic regions contiguous with stroma.
Full text 4,239 characters · extracted from oa-html · 2 sections · click to expand

Abstract

Cytokeratins are one of the intermediate cytoplasmic filaments which contribute to the cytoskeleton. Keratins have recently been demonstrated in normal and neoplastic tissues as well as in human cell lines. It has been suggested that the cellular location of keratin may reflect tissue-specific or epithelial type differentiation. Twenty-three examples of human ovaries containing the full spectrum of epithelial proliferations from inflammatory reactive processes to malignant neoplasia were studied for the cellular distribution of cytokeratin using antisera to human keratin. Nineteen cases contained immunoreactive keratin which was limited to the epithelial cells: 2/2 inflammatory, 8/10 benign tumors, 5/7 borderline tumors, 4/4 carcinomas. There was marked regional heterogeneity in keratin expression such that adjacent morphologically-identical cells could be functionally distinguished by the immunoreactive staining. The predominant cellular localization of keratin varied between histological tumor types in the benign neoplasms: serous=apical, subciliary; endometrioid=apical; mucinous=basal. This pattern was lost in the cytological progression to borderline and malignant tumors. In borderline tumors, the most intense reactivity was noted in areas of cellular atypia and proliferation. In borderline and malignant tumors, keratin was usually present in basal cytoplasmic regions contiguous with stroma. Key words: Keratin, Ovary, Cancer, Borderline tumors, Immunohistochemistry

References

- 1.Bamford PN, Ormerod MG, Sloane JP, Warburton MJ (1983) An immunohistochemical study of the distribution of epithelial antigens in the uterine cervix. Obstetrics and Gynecol 61:603–608 [PubMed] [Google Scholar] - 2.Banks-Schlegel SP (1982) Keratin alterations during embryonic epidermal differentiation: presage of adult epidermal maturation. J Biol Chem 93:551–559 [DOI] [PMC free article] [PubMed] [Google Scholar] - 3.Carson JM, Pinkus GS (1982) Mesothelioma profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol 108:80–88 [PMC free article] [PubMed] [Google Scholar] - 4.Connell ND, Rheinwald JG (1983) Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 34:245–253 [DOI] [PubMed] [Google Scholar] - 5.Franke WW, Appelhans B, Schmid E, Freudenstein C, Osborn M, Weber K (1979) The organization of cytokeratin filaments in intestinal epithelium. Eur J Cell Biol 19:255–268 [PubMed] [Google Scholar] - 6.Franke WW, Schmid E, Osborn M, Weber K (1978) Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci USA 75:5034–5038 (1978) [DOI] [PMC free article] [PubMed] [Google Scholar] - 7.Fuchs E, Green H (1980) Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 19:1033–1042 [DOI] [PubMed] [Google Scholar] - 8.Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Neville AM, Rudland PS (1982) Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 42:4763–4770 [PubMed] [Google Scholar] - 9.Mitchell DP and Gusterson BA (1982) Simultaneous demonstration of keratin and mucin. J Histochem Cytochem 30:707–709 [DOI] [PubMed] [Google Scholar] - 10.Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalogue of human cytokeratins: patterns of expression in normal epithelia, tumors, and cultured cells. Cell 31:11–24 [DOI] [PubMed] [Google Scholar] - 11.Ramaekers F, Puts J, Moesker O, Kant A, Jap P, Vooÿ P (1983) Demonstration of keratin in human adenocarcinomas. Am J Pathol 111:213–223 [PMC free article] [PubMed] [Google Scholar] - 12.Sun TT, Green H (1978) Keratin filaments of cultured human epidermal cells. J Biol Chem 253:2053–2060 [PubMed] [Google Scholar] - 13.Wu YJ, Parker LM, Binder NE, Becket MA, Sinard JH, Griffiths CT, Rheinwald JG (1982) The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 31:693–703 [DOI] [PubMed] [Google Scholar]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Keratins Ovarian Neoplasms Carcinoma Carcinoma Cell Division Epithelium Epithelium Female Humans Keratins Ovarian Neoplasms Ovarian Neoplasms Tissue Distribution

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:58:02.984372+00:00
unpaywall
last seen: 2026-10-30T06:30:42.975179+00:00